Clinical Trial Update: Effectiveness of Ofatumumab in Real-world Practice

View source ↗

Summary

This update reports the completion of a real-world effectiveness study of ofatumumab for multiple sclerosis, sponsored by Novartis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Kesimpta (ofatumumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Multiple Sclerosis | Status: COMPLETED